Evidence map›Paper›PMID 41113602›Full record

ArticleRSC advances2025

Discovery and characterization of phenoxyacetic acid derivatives as potential antiepileptic agents.

Mohamed K Elgohary, Mahmoud S Elkotamy, Mahmoud Abdelrahman Alkabbani, Abdulrahman A Almehizia, Ahmed M Naglah, Mohammed H Alqarni, Mohamed Fares, Wagdy M Eldehna, Hatem A Abdel-Aziz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohamed K ElgoharyPharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University Badr City Cairo 11829 Egypt mohamed-elgohary@eru.edu.eg.ORCID https://orcid.org/0000-0002-8269-9526
Mahmoud S ElkotamyScientific Research and Innovation Support Unit, Faculty of Pharmacy, Kafrelsheikh University Kafrelsheikh 33516 Egypt.
Mahmoud Abdelrahman AlkabbaniPharmacology and Toxicology Department, Faculty of Pharmacy, Egyptian-Russian University Badr City Cairo 11829 Egypt Mahmoud-Kabbani@eru.edu.eg.
Abdulrahman A AlmehiziaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P. O. Box 2457 Riyadh 11451 Saudi Arabia anaglah@ksu.edu.sa.ORCID https://orcid.org/0000-0001-8711-3873
Ahmed M NaglahDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University P. O. Box 2457 Riyadh 11451 Saudi Arabia anaglah@ksu.edu.sa.ORCID https://orcid.org/0000-0003-4377-5239
Mohammed H AlqarniDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University P. O. Box 173 Al-Kharj 11942 Saudi Arabia m.alqarni@psau.edu.sa.
Mohamed FaresPharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University Badr City Cairo 11829 Egypt mohamed-elgohary@eru.edu.eg.
Wagdy M EldehnaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University P. O. Box 33516 Kafrelsheikh Egypt.ORCID https://orcid.org/0000-0001-6996-4017
Hatem A Abdel-AzizApplied Organic Chemistry Department, National Research Center Dokki Cairo 12622 Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to discover novel multifunctional anticonvulsant agents through the evaluation of a series of test compounds 5d-f, 7b, and 10c-f, which were previously identified based on their potent anti-inflammatory activity in both

Identifiers

PMID41113602
PMCPMC12531995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.